Farag Kameel D.
SEC CIK 2093620 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AKTX | Akari Therapeutics Plc | Interim CFO | 23.3K | — | — | 5 | 2025-10-22 | 2026-08-17 |
Most active insiders at AKTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Farag Kameel D. | Interim CFO | — | — |
| 2 | Patel Samir Rashmikant | Dir, 10% | — | — |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-19 17:00 | 2026-08-17 | AKTX | Akari Therapeutics Plc | Farag Kameel D. | Interim CFO | A - Grant | $7.52 | +1,728 | 23.3K | +8% | +$13.0K | |
| 2026-08-05 18:30 | 2026-07-16 | AKTX | Akari Therapeutics Plc | Farag Kameel D. | Interim CFO | A - Grant | $11.50 | +1,130 | 21.6K | +6% | +$13.0K | |
| M | 2026-06-25 20:06 | 2026-06-24 | AKTX | Akari Therapeutics Plc | Farag Kameel D. | Interim CFO | A - Grant | $5.58 | +18.8K | 20.5K | +1,161% | +$105.0K |
| M | 2025-11-04 | 2025-11-01 | AKTX | Akari Therapeutics Plc | Farag Kameel D. | Interim CFO | A - Grant | $0.75 | +58.6K | 32.0K | New | +$44.0K |
| 2025-10-24 | 2025-10-22 | AKTX | Akari Therapeutics Plc | Farag Kameel D. | Interim CFO | A - Grant | $0.74 | +6,277 | 6,277 | New | +$4,645 |
Purchase Sale Sale after option exercise All abbreviations